Search for Roche Holding AG and
  1. August 25, 2014

    Roche: bets on discovery

    At one end of the pharma merger spectrum lies efficiency. Put two companies together and squeeze costs out. At the other...

  2. August 24, 2014

    Roche to buy InterMune for $8.3bn

    Roche has agreed to buy InterMune, the US biotech company, for $8.3bn in the latest example of the feverish deal activity...

  1. August 18, 2014

    Chugai shares soar on Roche buyout talk

    Shares in Japan’s Chugai Pharmaceutical soared to a record high on Monday on reports that Swiss drugmaker Roche was...

  2. August 18, 2014

    Roche / Chugai: uptown problems

    An uptown problem, if there ever was one: whatever to do with all that money. Roche has thrown off, on average, SFr12.6bn...

  3. Business Blog

    August 18, 2014

    Chugai and Roche: just good friends?

    The denial from Chugai Pharmaceutical could hardly have been more emphatic. No, Japan’s number three drugmaker by market...

  4. August 18, 2014

    Stocks advance as Ukraine worries ease

    Monday 21:00 BST. Global stocks started the week on a firm note amid easing concerns over the situation in Ukraine and a...

  5. August 15, 2014

    Roche to bid $10bn for full control of Japan’s Chugai

    Roche is set to offer $10bn to take full control of Japan’s Chugai Pharmaceuticals as the Swiss drugmaker looks to expand...

  6. August 8, 2014

    Roche clashes with UK watchdog on blocked cancer drug

    It has become a familiar dance: Britain’s drug costs watchdog rejects a new medicine as too expensive, prompting warnings...

  7. August 4, 2014

    Roche continues dealmaking with acquisition of Santaris

    Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group. Roche...

  8. July 24, 2014

    Roche profit falls as writedown and strong Swiss franc hit group

    Roche posted a 7 per cent fall in net profit in the first half of the year, after the Swiss pharmaceuticals group was hit by...

  9. July 23, 2014

    Delta gains on domestic demand underpin

    Delta Air Lines lifted the US airline sector on Wednesday after it said results were underpinned by strong domestic demand,...

  10. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  11. July 2, 2014

    Roche to buy US cancer drug group Seragon

    Roche has agreed to buy Seragon Pharmaceuticals, a privately owned US biotech company, for up to $1.7bn, in a deal that...

  12. June 30, 2014

    Roche rebuts criticism of Tamiflu stockpiling

    Roche has hit back against what it termed a “seriously flawed” study that said the UK government had wasted almost £500m...

  13. June 2, 2014

    Roche to buy Genia of US for up to $350m

    Roche is to buy the US gene-sequencing company Genia in a deal that could cost up to $350m, as the Swiss pharmaceuticals...

  14. May 30, 2014

    Hopes for cancer cures offer comfort for battered pharma

    It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

  15. May 29, 2014

    Italian health ministry to seek €1.2bn from Roche and Novartis

    Italy’s health ministry said that it plans to seek damages of €1.2bn from Roche and Novartis after the Italian antitrust...

  16. May 23, 2014

    Chinese officials deny Roche visit was bribery-related

    Local government officials in the eastern Chinese city of Hangzhou on Friday denied that a visit this week to the local...

  17. April 15, 2014

    Roche drug boosts to revenue counteracted by currency’s strength

    Roche’s revenues fell 1 per cent in the first quarter as the strength of the Swiss franc weighed on the pharma group, even...

  18. April 11, 2014

    Big pharma: Storehouse of trouble

    Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts...

  19. April 10, 2014

    French probe alleged drug collusion

    France’s competition authority is investigating Roche and Novartis over alleged collusion to protect one of their...

  20. March 26, 2014

    Kim Lim: Carvings, Roche Court, Wiltshire, UK – review

    Set amid lush Wiltshire countryside, the New Art Centre’s luminous gallery at Roche Court is an ideal setting for Kim Lim....

  21. March 13, 2014

    Lufthansa revives dividend as restructuring efforts take effect

    Lufthansa reinstated its dividend as the restructuring of its European network began to bear fruit; the German airline also...

  22. March 4, 2014

    Roche chairman fears for R&D amid squeeze on investment

    Europe risks losing investment in research and development because of the reluctance of cash-strapped governments to pay for...

  23. February 7, 2014

    Roche wins battle against India sales of generic cancer drug

    Two generic pharmaceutical companies have been ordered to stop selling their version of a Roche breast cancer treatment in...

  24. January 30, 2014

    Roche to lead way on corporate governance crackdown

    Roche will become one of the first big Swiss companies to implement tough new corporate governance rules designed to remove...

  25. January 29, 2014

    Novartis considers future of $14bn Roche stake

    Novartis’s $14bn stake in its local rival Roche is one of the assets it is scrutinising as part of a broader review of its...

  26. January 27, 2014

    Hepatitis C: Treated – at a price

    Gemma Peppe lived with hepatitis C for two decades before she – and the teenage son she inadvertently infected at birth –...

  27. January 8, 2014

    AstraZeneca strikes deal with UK’s Immunocore

    AstraZeneca has struck a deal with a fast-growing UK biotech company to develop treatments that use the body’s immune system...

  28. October 17, 2013

    Roche / Novartis: combination therapy

    Winter might be descending on the Alps, but spring is in the air in Basel. The Swiss city, home to Roche and Novartis, has...

  29. September 30, 2013

    Roche chief Severin Schwan open to co-operation with Novartis

    Roche’s chief executive has signalled openness to renewed co-operation with counterparts at his Swiss rival Novartis, in a...

  30. September 30, 2013

    Europe belt tightening will hit pharma, warns Roche chief

    Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and...

  31. September 27, 2013

    QI is an option when good buys are scarce

    Even the world’s greatest stockpicker thinks there’s not much good value to be had. “We’re having a hard time finding things...

  32. September 16, 2013

    Roche poaches Lufthansa chief executive Christoph Franz

    Christoph Franz is to step down as chief executive of Lufthansa midway through the German airline’s restructuring programme...

  33. September 4, 2013

    Why are good managers such a rare species?

    Becoming a better boss: Why good management is so difficult, by Julian Birkinshaw, Wiley, RRP£18.99 How likely is it that...

  34. September 3, 2013

    BioMérieux buys privately held BioFire for $450m

    BioMérieux, the quoted French diagnostics company, is to pay $450m to buy a US rival in a deal designed to reinforce and...

  35. August 16, 2013

    Roche drops patent for Herceptin in India

    Roche, the Swiss drugmaker, has decided to relinquish its patent on the breast cancer drug Herceptin in the Indian market,...

  36. August 12, 2013

    Pharmaceuticals: Back to the lab

    He has promised no big shift in strategy or focus, spurned big acquisitions and suffered a series of research setbacks. Yet...

  37. August 8, 2013

    Surgery needed to keep Novartis in shape

    The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

  38. July 25, 2013

    Roche chief Severin Schwan plays down risk of graft scandal in China

    Roche’s chief executive played down the dangers of the corruption scandal that has embroiled GlaxoSmithKline in China for...

Search for Roche Holding AG and